Savvy Updates, 5/6/24: Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”
Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...
Savvy Updates, 4/29/24: Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)
Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
Savvy Updates, 4/22/24: Statements of Insulin Shortages, FDA Drug Shortages, GLP-1s for T1D, Red Light Therapy Reduces BG, Best Low-Carb Yogurts
JDRF Statement and Update on Insulin Shortage by JDRF.org/press-releases, April 2024. JDRF is aware that, unfortunately, individuals are having trouble filling their prescriptions for 10mL Humalog, 10mL Insulin Lispro, and 10mL Novolog vials. It is unacceptable that...
Savvy Updates, 4/15/24: Lilly’s Humalog Shortage & More, T1D Diabetes Moonshot, The Ozempic Jingle
Lilly’s Carelessness in Discontinuing 3 mL vials of Humalog Causes Shortages in 10 mL vials of Humalog + Unbranded Lispro by Scott Strumello for blog.sstrumello.com, 9 April 2024. In mid-March 2024, the JDRF shared news about how Eli Lilly & Company,...
More Diabetes Blogs